Metabolite Reference Standards and Reagents: All Compounds

Click the Common Name to see compound details, download synthesis reports, and request completed compounds.

Search:

Fields searched:
Common name, InChiKey, IUPAC name, Synonyms, PubChem CID, Pathway Cassette, Status (case insensitive)

Browse by Pathway Cassette

CNID	Common Name	InChiKey	Isotopic Label Type	Isotopic Label Position	Pathway Cassette	MSSC	Status	Request this compound
210	Symmetric Dimethylarginine	HVPFXCBJHIIJGS-LURJTMIESA-N			Epigenetics		nominated
179	18-Hydroxy-1,18,18-trideuterocorticosterone	WTPMRQZHJLJSBO-BYUZBNOLSA-N			Steroids/bioactive lipids	RTI	synthesis in process
175	(6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic acid, chloride	NDMWNIVQVBEIJX-ZEDZUCNESA-N			Folates/1C metabolism	RTI	completed ^‡	REQUEST
177	18-hydroxy-1,18,18-trideuterocortisol	HESFZGWRDUVOMS-YTTWDCMTSA-N			Steroids/bioactive lipids	RTI	synthesis in process ^‡
90	Glucosyl (β) sphingosine (d17:1)	DQIGRQVQNXMBJY-XAYNVVOESA-N			Steroids/bioactive lipids	NA	declined
173	5-Formimino-tetrahydrofolic acid	YCWUVLPMLLBDCU-OLZOCXBDSA-N			Folates/1C metabolism	RTI	completed ^‡	REQUEST
7	2-keto-3-deoxygluconate	WPAMZTWLKIDIOP-WVZVXSGGSA-N			Miscellaneous/drugs	SRI	completed	REQUEST
216	5-formylcytosine	FHSISDGOVSHJRW-UHFFFAOYSA-N			Epigenetics	SRI	completed	REQUEST
215	5-carboxylcytosine	BLQMCTXZEMGOJM-UHFFFAOYSA-N			Epigenetics	SRI	completed	REQUEST
178	11-keto-1,6,7-trideuterotestosterone	WTPMRQZHJLJSBO-FLDABYKKSA-N			Steroids/bioactive lipids	RTI	completed	REQUEST
220	Metabolon Lactone X12063	IJIWKJRHDDIJKI-HGEVZRBZSA-N			Miscellaneous/drugs		nominated
40	10-Formyl-tetrahydrofolic acid	AUFGTPPARQZWDO-YUZLPWPTSA-N			Folates/1C metabolism	RTI	completed	REQUEST
6	Malioxamycin	KXQRAPMNPUXYGT-VDTYLAMSSA-N			Miscellaneous/drugs	RTI	completed	REQUEST
9	Creatine Riboside	BGJFEKXALPJEGN-XVFCMESISA-N				SRI	dropped
221	2-Oxo-20-trihydroxy-leukotriene B4	QVZXILIWUPKGPA-CYHXRQOESA-N			Steroids/bioactive lipids		nominated
224	5-Hydroxymethyl-2’-deoxycytidine-4,5,hydroxymethyl-13C3						synthesis in process ^‡
96	fructose 2,6 bisphosphate	YXWOAJXNVLXPMU-ZXXMMSQZSA-N			Glycolysis	SRI	synthesis in process ^*
230	UDP-NAcglucosamine		13	¹³C₆ hexose			nominated
227	UDP-glucose		¹³C	glucose subunit, all 6 positions			nominated
222	5-carboxy-2'-dCytosine	FHPQEVWDHUHVGT-RRKCRQDMSA-N	¹³C	all carbons on the cytosine	Epigenetics		synthesis in process
229	GDP Mannose		¹³C	all 6 position in the mannose subunit			nominated
211	Symmetric Dimethylarginine labeled	HVPFXCBJHIIJGS-LURJTMIESA-N	¹³C	All carbons	Epigenetics		nominated
77	2-hydroxyglutaric acid	HWXBTNAVRSUOJR-UHFFFAOYSA-N	¹³C	uniform enrichment	Krebs cycle	SRI	completed	REQUEST
76	Itaconic acid	LVHBHZANLOWSRM-UHFFFAOYSA-N	¹³C	uniform enrichment though any 2 positions also would suffice	Krebs cycle	SRI	completed	REQUEST
232	iso palmitic acid	ZONJATNKKGGVSU-UHFFFAOYSA-N	¹³C	13,14,15,15'-¹³C4			nominated
223	5-formyl-2'-deoxycytosine	QBADNGFALQJSIH-XLPZGREQSA-N	¹³C	All of the cytosine ring	Epigenetics		synthesis in process
26	Dimethyl α-ketoglutarate	TXIXSLPEABAEHP-UHFFFAOYSA-N	¹³C	1,2,3,4,5-¹³C5	Krebs cycle	RTI	completed	REQUEST
228	UDP-galactose		¹³C	all 6 C in hexose			nominated
217	1-Monoethyl malate	FHHFKGGCXNOIAY-PTQBSOBMSA-N	¹³C	1 position of malate	Krebs cycle	SRI	synthesis in process
213	13CD3-QA Iodide	CSRAQSNOQWXULC-HBKQTYJLSA-M	¹³C + ²H	both on one mehyl group	Reagents	SRI	completed	REQUEST
11	Fumaric acid (2,3-13C and 2,3-2H labeled)	VZCYOOQTPOCHFL-OWOJBTEDSA-N	¹³C, ²H	2,3	Krebs cycle	NA	declined
5	rel-[13C]Tetrahydroxyphenanthrene	NXXFPJMAQQHDHQ-OANWKOAXSA-N	¹³C₆	ring-¹³C₆	Miscellaneous/drugs	SRI	synthesis in process
214	15NQDA	CSRAQSNOQWXULC-XOJMRSMASA-M	¹⁵N	2-¹⁵Naminooxyethyl	Reagents	SRI	completed	REQUEST
83	15N-Cholamine Bromide	VSZWLDAGOXQHNB-NWZHYJCUSA-M	¹⁵N	Please see Anal Chem. 2013 Sep 17;85(18):8715-21.	Reagents	SRI	completed	REQUEST
226	[15N2,13C]-5-Formylcytosine	FHSISDGOVSHJRW-QIOHBQFSSA-N	¹⁵N, ¹³C			SRI	completed	REQUEST
225	[15N2,13C]-5-Carboxycytosine	BLQMCTXZEMGOJM-QIOHBQFSSA-N	¹⁵N, ¹³C			SRI	completed	REQUEST
84	NADP-stable isotope label	XJLXINKUBYWONI-NNYOXOHSSA-O	1H,¹³C,¹⁵N or any combination thereof	and that are stable to back-exchange	Redox/coenzymes	RTI	synthesis in process ^†
231	CDP-choline		²H	perdeuteration of choline (D13)			synthesis in process
85	NADPH	ACFIXJIJDZMPPO-NNYOXOHSSA-N	²H,¹³C,¹⁵N at least 5, in any combination	any 5 atoms or more	Redox/coenzymes	RTI	synthesis in process ^†
82	NAD+ labeled	BAWFJGJZGIEFAR-NNYOXOHSSA-O	²H,¹³C, or ¹⁵N or combinations thereof	Any 5-should be more than 4 total	Redox/coenzymes	RTI	synthesis in process ^†
81	NADH	BOPGDPNILDQYTO-NNYOXOHSSA-N	²H,¹³C, or ¹⁵N or combinations thereof	Any 5-should be more than 4 total	Redox/coenzymes	RTI	synthesis in process ^†
60	D-Sedoheptulose-7-phosphate	CBIDVWSRUUODHL-QTSLKERKSA-N	¹³C	either C1+C2 or C3 to C7	Pentose phosphate: non-oxidative branch	SRI	synthesis in process ^†
52	glucose-6-phosphate	NBSCHQHZLSJFNQ-GASJEMHNSA-N	¹³C	uniform enrichment	Glycolysis	SRI	completed	REQUEST
53	Fructose-6-phosphate	BGWGXPAPYGQALX-ARQDHWQXSA-N	¹³C	uniform enrichment	Glycolysis	SRI	completed	REQUEST
59	D-Xylulose 5-phosphate	FNZLKVNUWIIPSJ-RFZPGFLSSA-N	¹³C	uniform enrichment	Pentose phosphate: non-oxidative branch	SRI	synthesis in process
57	D-Ribulose 5-phosphate	FNZLKVNUWIIPSJ-UHNVWZDZSA-N	¹³C	uniform enrichment	Pentose phosphate: oxidative branch	SRI	completed	REQUEST
71	U13C-(–)-4,5-Dihydroorotic acid	UFIVEPVSAGBUSI-UHFFFAOYSA-N	¹³C		Nucleotide pathways: pyrimidine biosynthesis	RTI	completed	REQUEST
74	(6R)-5,10-methylenetetrahydrofolate	QYNUQALWYRSVHF-OLZOCXBDSA-N	¹³C		Folates/1C metabolism	RTI	synthesis in process ^‡
70	Carbamoyl phosphate	FFQKYPRQEYGKAF-UHFFFAOYSA-N	¹³C		Nucleotide pathways: pyrimidine biosynthesis	RTI	completed	REQUEST
54	6-phosphogluconolactone	IJOJIVNDFQSGAB-SQOUGZDYSA-N	¹³C	uniform enrichment	Pentose phosphate: oxidative branch	SRI	completed	REQUEST
61	D-Erythrose 4-phosphate	NGHMDNPXVRFFGS-IUYQGCFVSA-N	¹³C	uniform enrichment	Pentose phosphate: non-oxidative branch	SRI	synthesis in process
55	6-phosphogluconic acid	BIRSGZKFKXLSJQ-SQOUGZDYSA-N	¹³C	uniform enrichment	Pentose phosphate: oxidative branch	SRI	completed	REQUEST
58	D-Ribose 5-phosphate	KTVPXOYAKDPRHY-SOOFDHNKSA-N	¹³C	uniform enrichment	Pentose phosphate: non-oxidative branch	SRI	completed	REQUEST
72	Orotic-4,5,6-carboxy-13C4 Acid Monohydrate	PXQPEWDEAKTCGB-UHFFFAOYSA-N	¹³C		Nucleotide pathways: pyrimidine biosynthesis	RTI	completed	REQUEST
73	U13C-AICA Ribonucleotide	NOTGFIUVDGNKRI-UUOKFMHZSA-N	¹³C		Nucleotide pathways: purine biosynthesis	RTI	completed	REQUEST
219	mono-ethylfumarate (carbon-13 labeled at the 1 and 4 positions of fumarate)	XLYMOEINVGRTEX-JUAXEOANSA-N	¹³C	The 1 and 4 position of fumarate	Krebs cycle	SRI	synthesis in process
180	11β-Hydroxyandrostenedione-d3		²H	carbons 1,6,7	Steroids/bioactive lipids	RTI	completed ^‡	REQUEST
176	18-hydroxy-1,6,7-trideuterocortisol	HESFZGWRDUVOMS-AZFBHEKGSA-N	²H		Steroids/bioactive lipids	RTI	synthesis in process ^‡
44	11β-hydroxyandrostenedione (d-4)	WSCUHXPGYUMQEX-KCZNZURUSA-N	²H	at carbons 1,2,6,7	Steroids/bioactive lipids	RTI	nominated ^†
15	D-glucose (Uniformly deuterated. 13C labeled at the C3 and C4 positions)	WQZGKKKJIJFFOK-GASJEMHNSA-N	²H, ¹³C	[U-D, 3,4-¹³C]glucose	Glycolysis	NA	declined
43	18β-hydroxycortisol	HESFZGWRDUVOMS-FJNAKSJRSA-N	either -d3 or ¹³C3 or greater	any non-exhangeable position	Steroids/bioactive lipids	RTI	synthesis in process ^†
8	3-Deoxyarabino-hexonic acid	YGMNHEPVTNXLLS-VAYJURFESA-N	NA	NA	Miscellaneous/drugs	SRI	completed	REQUEST
27	Resolvin E1	AOPOCGPBAIARAV-OTBJXLELSA-N	n/a	n/a	Steroids/bioactive lipids	NA	declined
45	18-oxo-tetrahydrocortisol	ONUUOQCMEFWOSB-ASTGPZOCSA-N	NA	NA	Steroids/bioactive lipids	RTI	synthesis in process
95	fructose 2,6 bisphosphate		U-¹³C	U-¹³C	Glycolysis	SRI	synthesis in process
204	NADP+ labeled		uniform enrichment		Redox/coenzymes	RTI	synthesis in process ^‡
201	NADPH		uniform enrichment		Redox/coenzymes	RTI	synthesis in process ^‡
205	NAD+		uniform enrichment		Redox/coenzymes	RTI	synthesis in process ^‡
203	NADH labeled		uniform enrichment		Redox/coenzymes	RTI	synthesis in process ^‡
218	Acetaminophen	RZVAJINKPMORJF-UHFFFAOYSA-N	Uniformly ¹³C labeled acetaminophen	All carbon (eight carbon)	Miscellaneous/drugs		nominated
183	Dimethyl α-ketoglutarate	TXIXSLPEABAEHP-UHFFFAOYSA-N	unlabelled parent^*		Krebs cycle	RTI	completed ^*	REQUEST
197	AICA Ribonucleotide	XOGIBYSEXZJKHY-UIPKGFOGSA-N	unlabelled parent^*		Nucleotide pathways: purine biosynthesis	RTI	completed ^*	REQUEST
174	(6R,S)-5,10-Methylene-5,6,7,8-tetrahydrofolic acid, calcium salt	AKUPTUNGFOADRT-ZEDZUCNESA-L	unlabelled parent^*		Folates/1C metabolism	RTI	completed ^*	REQUEST
199	NADH	BOPGDPNILDQYTO-NNYOXOHSSA-N	unlabelled parent^*		Redox/coenzymes	RTI	synthesis in process ^*
212	QDA Iodide	CSRAQSNOQWXULC-UHFFFAOYSA-M	unlabelled parent^*		Reagents	SRI	completed	REQUEST
200	NADP+	XJLXINKUBYWONI-NNYOXOHSSA-O	unlabelled parent^*		Redox/coenzymes	RTI	synthesis in process ^*
202	Cholamine Bromide	VSZWLDAGOXQHNB-UHFFFAOYSA-M	unlabelled parent^*		Reagents	SRI	completed ^*	REQUEST
182	rel-Tetrahydroxyphenanthrene		unlabelled parent^*		Miscellaneous/drugs	SRI	synthesis in process ^*
196	Dihydroorotic acid	UFIVEPVSAGBUSI-UHFFFAOYSA-N	unlabelled parent^*		Nucleotide pathways: pyrimidine biosynthesis	RTI	synthesis in process ^*
194	Carbamoyl phosphate	FFQKYPRQEYGKAF-UHFFFAOYSA-N	unlabelled parent^*		Nucleotide pathways: pyrimidine biosynthesis	RTI	synthesis in process ^*
198	NAD+	BAWFJGJZGIEFAR-NNYOXOHSSA-O	unlabelled parent^*		Redox/coenzymes	RTI	synthesis in process ^*
181	11β-Hydroxyandrostenedione	WSCUHXPGYUMQEX-KCZNZURUSA-N	unlabelled parent^*		Steroids/bioactive lipids	RTI	completed ^*	REQUEST
186	18-Hydroxycortisol	HESFZGWRDUVOMS-UKSDXMLSSA-N	unlabelled parent^*		Steroids/bioactive lipids	RTI	synthesis in process ^*
187	18-Hydroxycorticosterone	HFSXHZZDNDGLQN-ZVIOFETBSA-N	unlabelled parent^*		Steroids/bioactive lipids	RTI	synthesis in process ^*
206	NADPH	ACFIXJIJDZMPPO-NNYOXOHSSA-N	unlabelled parent^*		Redox/coenzymes	RTI	synthesis in process ^*

Number of records: 85

^* This non-target unlabelled compound was analyzed by chromatographic and spectral methods as appropriate but was not certified by GLP protocols.
^† One of more compounds were approved for synthesis based on this nomination. Click the common name for details.
^‡ This compound was approved for synthesis based on the nomination of a different compound, or a nomination that was not specific.

See compounds approved for synthesis | completed compounds